CRYSTAL ORLOSKY: Open Payments
NPI 1932948593 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 53 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $577 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 40 | $604 |
| Neurocrine BioSciences, Inc. | 8 | $187 |
| Viatris Specialty LLC | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
Products named: AUSTEDO XR, INGREZZA, YUPELRI, REXULTI.
Industry payments across PA — which companies pay providers there.
